Tivic Health Systems (TIVC) Competitors

$1.11
-0.02 (-1.77%)
(As of 04/24/2024 ET)

TIVC vs. NUWE, NDRA, HSDT, SDCCQ, GRI, BJDX, NBSE, GLMD, PRFX, and PBLA

Should you be buying Tivic Health Systems stock or one of its competitors? The main competitors of Tivic Health Systems include Nuwellis (NUWE), ENDRA Life Sciences (NDRA), Helius Medical Technologies (HSDT), SmileDirectClub (SDCCQ), GRI Bio (GRI), Bluejay Diagnostics (BJDX), NeuBase Therapeutics (NBSE), Galmed Pharmaceuticals (GLMD), PainReform (PRFX), and Panbela Therapeutics (PBLA). These companies are all part of the "medical" sector.

Tivic Health Systems vs.

Tivic Health Systems (NASDAQ:TIVC) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Nuwellis has a net margin of -227.99% compared to Tivic Health Systems' net margin of -701.02%. Tivic Health Systems' return on equity of -186.19% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Tivic Health Systems-701.02% -186.19% -138.20%
Nuwellis -227.99%-218.79%-140.88%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tivic Health Systems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Nuwellis
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Tivic Health Systems has a beta of 2.88, meaning that its stock price is 188% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500.

4.3% of Tivic Health Systems shares are held by institutional investors. Comparatively, 3.1% of Nuwellis shares are held by institutional investors. 2.7% of Tivic Health Systems shares are held by company insiders. Comparatively, 0.9% of Nuwellis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Nuwellis received 19 more outperform votes than Tivic Health Systems when rated by MarketBeat users.

CompanyUnderperformOutperform
Tivic Health SystemsN/AN/A
NuwellisOutperform Votes
19
50.00%
Underperform Votes
19
50.00%

In the previous week, Nuwellis had 1 more articles in the media than Tivic Health Systems. MarketBeat recorded 1 mentions for Nuwellis and 0 mentions for Tivic Health Systems. Nuwellis' average media sentiment score of 0.67 beat Tivic Health Systems' score of 0.00 indicating that Nuwellis is being referred to more favorably in the news media.

Company Overall Sentiment
Tivic Health Systems Neutral
Nuwellis Positive

Tivic Health Systems has higher earnings, but lower revenue than Nuwellis. Tivic Health Systems is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tivic Health Systems$1.18M1.38-$8.24M-$42.48-0.03
Nuwellis$8.86M0.21-$20.21M-$13.46-0.02

Summary

Tivic Health Systems and Nuwellis tied by winning 7 of the 14 factors compared between the two stocks.

Get Tivic Health Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for TIVC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TIVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TIVC vs. The Competition

MetricTivic Health SystemsElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.63M$3.09B$4.82B$7.47B
Dividend YieldN/A1.80%5.47%3.96%
P/E Ratio-0.0312.10185.8116.66
Price / Sales1.3863.222,314.8480.58
Price / CashN/A51.5645.6834.56
Price / Book0.453.754.644.28
Net Income-$8.24M$87.48M$102.53M$213.77M
7 Day Performance0.01%1.45%-0.21%0.96%
1 Month Performance-18.97%3.64%-6.33%-4.43%
1 Year Performance-91.90%-0.33%9.38%7.54%

Tivic Health Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NUWE
Nuwellis
0 of 5 stars
$0.34
-8.2%
N/A-93.1%$2.28M$8.86M-0.0259News Coverage
Gap Down
NDRA
ENDRA Life Sciences
0 of 5 stars
$0.27
+3.8%
N/A-85.9%$3.04MN/A-0.1421Gap Up
HSDT
Helius Medical Technologies
1.2829 of 5 stars
$5.32
-8.6%
$54.50
+924.4%
-51.4%$4.74M$640,000.00-0.3726Gap Down
SDCCQ
SmileDirectClub
0 of 5 stars
$0.00
flat
N/AN/A$1.61M$470.74M-0.012,700Gap Down
GRI
GRI Bio
0 of 5 stars
0.52
-1.2%
N/AN/A$1.68MN/A-0.011Positive News
Gap Up
BJDX
Bluejay Diagnostics
0 of 5 stars
$0.57
-3.4%
N/A-90.6%$1.53M$250,000.00-0.0610News Coverage
NBSE
NeuBase Therapeutics
0 of 5 stars
$0.40
-2.4%
N/A-86.2%$1.52MN/A-0.0537Negative News
Gap Down
GLMD
Galmed Pharmaceuticals
0 of 5 stars
$0.35
-7.9%
N/A-92.8%$1.76MN/A-0.114Analyst Report
News Coverage
PRFX
PainReform
0 of 5 stars
$0.81
-17.3%
N/A-85.4%$1.40MN/A0.007Gap Down
High Trading Volume
PBLA
Panbela Therapeutics
0.6293 of 5 stars
$0.53
-3.7%
$500.00
+95,138.1%
-99.8%$1.83MN/A0.006Gap Down

Related Companies and Tools

This page (NASDAQ:TIVC) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners